Sonoma Pharmaceuticals (SNOA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.15, -0.86% vs the prior close of $1.16.
- Volume 31.30K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SNOA dips 0.9% to $1.15, a 1-month low, 4 down days in a row. Closed at $1.15, -0.86% vs the prior close of $1.16. Day range $1.12–$1.21, opened at $1.15.
SNOA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — SNOA dips 0.9% to $1.15, a 1-month low, 4 down days in a row
- Closed at $1.15, -0.86% vs the prior close of $1.16. Day range $1.12–$1.21, opened at $1.15.
- Volume was 31.30K shares, 0.2x its 50-day average of 126.13K — lighter than usual.
- Price is -10.5% vs its 50-day average ($1.28) and -37.5% vs its 200-day average ($1.84).
- 52-week range $0.85–$4.25; today's close sits at 9% of that range, 72.9% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — SNOA dips 1.7% to $1.16, 3 down days in a row
- Closed at $1.16, -1.69% vs the prior close of $1.18. Day range $1.13–$1.18, opened at $1.16.
- Volume was 49.10K shares, 0.4x its 50-day average of 126.60K — lighter than usual.
- Price is -9.7% vs its 50-day average ($1.28) and -37.4% vs its 200-day average ($1.85).
- 52-week range $0.85–$4.25; today's close sits at 9% of that range, 72.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — SNOA slides 4.1% to $1.18
- Closed at $1.18, -4.07% vs the prior close of $1.23. Day range $1.17–$1.25, opened at $1.25.
- Volume was 47.70K shares, 0.4x its 50-day average of 126.59K — lighter than usual.
- Price is -8.2% vs its 50-day average ($1.28) and -36.7% vs its 200-day average ($1.86).
- 52-week range $0.85–$4.25; today's close sits at 10% of that range, 72.2% below the 52-week high.
Oct 12, 2026 — SNOA ends flat (+0.0%) to $1.23
- Closed at $1.23, +0.00% vs the prior close of $1.23. Day range $1.22–$1.29, opened at $1.24.
- Volume was 14.80K shares, 0.1x its 50-day average of 126.86K — lighter than usual.
- Price is -4.2% vs its 50-day average ($1.28) and -34.5% vs its 200-day average ($1.88).
- 52-week range $0.85–$4.30; today's close sits at 11% of that range, 71.4% below the 52-week high.
Oct 9, 2026 — SNOA jumps 6.0% to $1.23
- Closed at $1.23, +6.03% vs the prior close of $1.16. Day range $1.16–$1.26, opened at $1.17.
- Volume was 49.30K shares, 0.4x its 50-day average of 126.19K — lighter than usual.
- Price is -4.0% vs its 50-day average ($1.28) and -34.9% vs its 200-day average ($1.89).
- 52-week range $0.85–$4.44; today's close sits at 11% of that range, 72.3% below the 52-week high.
Oct 8, 2026 — SNOA slides 4.9% to $1.16, a 1-month low
- Closed at $1.16, -4.92% vs the prior close of $1.22. Day range $1.14–$1.20, opened at $1.20.
- Volume was 89.00K shares, 0.7x its 50-day average of 125.12K.
- Price is -9.3% vs its 50-day average ($1.28) and -39.0% vs its 200-day average ($1.90).
- 52-week range $0.85–$4.44; today's close sits at 9% of that range, 73.9% below the 52-week high.
Oct 7, 2026 — SNOA dips 0.8% to $1.22
- Closed at $1.22, -0.81% vs the prior close of $1.23. Day range $1.20–$1.23, opened at $1.23.
- Volume was 31.60K shares, 0.3x its 50-day average of 125.29K — lighter than usual.
- Price is -4.5% vs its 50-day average ($1.28) and -36.2% vs its 200-day average ($1.91).
- 52-week range $0.85–$4.45; today's close sits at 10% of that range, 72.6% below the 52-week high.
Oct 6, 2026 — SNOA rises 0.8% to $1.23
- Closed at $1.23, +0.82% vs the prior close of $1.22. Day range $1.21–$1.27, opened at $1.27.
- Volume was 44.70K shares, 0.4x its 50-day average of 124.90K — lighter than usual.
- Price is -3.6% vs its 50-day average ($1.28) and -36.1% vs its 200-day average ($1.92).
- 52-week range $0.85–$4.60; today's close sits at 10% of that range, 73.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — SNOA dips 1.6% to $1.22, a 1-month low, 3 down days in a row
- Closed at $1.22, -1.61% vs the prior close of $1.24. Day range $1.22–$1.25, opened at $1.24.
- Volume was 18.60K shares, 0.1x its 50-day average of 125.71K — lighter than usual.
- Price is -4.3% vs its 50-day average ($1.27) and -37.0% vs its 200-day average ($1.94).
- 52-week range $0.85–$4.60; today's close sits at 10% of that range, 73.5% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — SNOA dips 0.8% to $1.24
- Closed at $1.24, -0.80% vs the prior close of $1.25. Day range $1.22–$1.29, opened at $1.28.
- Volume was 27.40K shares, 0.2x its 50-day average of 125.45K — lighter than usual.
- Price is -2.6% vs its 50-day average ($1.27) and -36.3% vs its 200-day average ($1.95).
- 52-week range $0.85–$4.60; today's close sits at 10% of that range, 73.0% below the 52-week high.
SNOA latest news & SEC filings
Every SEC filing by or about SNOA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-A12B/A — 8-A12B/A filing
8-A12B/A filing
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $6.41M (prior year $4.01M) (+59.6% vs Jun 30, 2025)
- Net income: -$330.00K (prior year -$1.24M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.09 (prior year -$0.76) (loss narrowed vs Jun 30, 2025)
Jul 28, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 23, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 24, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Things to know before you trade SNOA
- Last results release: Nov 8, 2018 (8-K Item 2.02). Previous ones: Aug 8, 2018, Jun 13, 2018, Feb 7, 2018. Based on that rhythm, the next report is likely around Feb 7, 2019 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.07% (largest 6.0%).
- Liquidity: about 46.02K shares (≈$52.92K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.15 vs a range of $0.85–$4.25 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 6, 2026; 8-K Sep 17, 2026; 8-K Aug 19, 2026.
- Share count: 4.79M shares outstanding (Aug 6, 2026), +191.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
SNOA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.15 | 1.21 | 1.12 | 1.15 | 31.30K |
| Oct 14, 2026 | 1.16 | 1.18 | 1.13 | 1.16 | 49.10K |
| Oct 13, 2026 | 1.25 | 1.25 | 1.17 | 1.18 | 47.70K |
| Oct 12, 2026 | 1.24 | 1.29 | 1.22 | 1.23 | 14.80K |
| Oct 9, 2026 | 1.17 | 1.26 | 1.16 | 1.23 | 49.30K |
| Oct 8, 2026 | 1.20 | 1.20 | 1.14 | 1.16 | 89.00K |
| Oct 7, 2026 | 1.23 | 1.23 | 1.20 | 1.22 | 31.60K |
| Oct 6, 2026 | 1.27 | 1.27 | 1.21 | 1.23 | 44.70K |
| Oct 5, 2026 | 1.24 | 1.25 | 1.22 | 1.22 | 18.60K |
| Oct 2, 2026 | 1.28 | 1.29 | 1.22 | 1.24 | 27.40K |
| Oct 1, 2026 | 1.31 | 1.31 | 1.25 | 1.25 | 35.30K |
| Sep 30, 2026 | 1.24 | 1.30 | 1.20 | 1.28 | 110.70K |
| Sep 29, 2026 | 1.27 | 1.28 | 1.24 | 1.25 | 7.60K |
| Sep 28, 2026 | 1.29 | 1.29 | 1.24 | 1.26 | 30.40K |
| Sep 25, 2026 | 1.24 | 1.29 | 1.24 | 1.27 | 24.30K |
| Sep 24, 2026 | 1.24 | 1.29 | 1.20 | 1.25 | 77.70K |
| Sep 23, 2026 | 1.31 | 1.31 | 1.25 | 1.25 | 41.50K |
| Sep 22, 2026 | 1.27 | 1.30 | 1.26 | 1.30 | 14.40K |
| Sep 21, 2026 | 1.28 | 1.28 | 1.25 | 1.25 | 27.60K |
| Sep 18, 2026 | 1.26 | 1.34 | 1.24 | 1.28 | 147.40K |
About Sonoma Pharmaceuticals
Sonoma Pharmaceuticals (SNOA) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in BOULDER, CO. State of incorporation: DE. Fiscal year ends March 31. SEC CIK 1367083.
SNOA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jay E Birnbaum | Director | Jan 2, 2026 |
| Vanessa Jacoby | Director | Jul 9, 2026 |
| John Mclaughlin | Director | Jul 9, 2026 |
| Philippe Weigerstorfer | Director | Jul 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jerome J Dvonch | Chief Financial Officer | Jul 9, 2026 |
| Poggetto John Dal | Controller | Jul 9, 2026 |
| Amy Moss Trombly | Chief Executive Officer | Jul 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SNOA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2026 | $19.53M | $-3.17M | -1.89 | $-3.93M |
| Mar 31, 2025 | $14.29M | $-3.46M | -2.79 | $-88.00K |
| Mar 31, 2024 | $12.73M | $-4.83M | -10.63 | $-2.40M |
| Mar 31, 2023 | $13.27M | $-5.15M | -1.52 | $-6.15M |
| Mar 31, 2022 | $12.63M | $-5.09M | -1.92 | $-4.25M |
Latest balance sheet: total assets $18.11M, total liabilities $11.51M, cash $5.34M (as of Jun 30, 2026).
SNOA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Nov 8, 2018 | 8-K Item 2.02 (results) | — |
| Aug 8, 2018 | 8-K Item 2.02 (results) | — |
| Jun 13, 2018 | 8-K Item 2.02 (results) | — |
| Feb 7, 2018 | 8-K Item 2.02 (results) | — |
| Nov 9, 2017 | 8-K Item 2.02 (results) | — |
| Aug 8, 2017 | 8-K Item 2.02 (results) | — |
| Jun 5, 2017 | 8-K Item 2.02 (results) | — |
| Feb 9, 2017 | 8-K Item 2.02 (results) | — |
| Nov 10, 2016 | 8-K Item 2.02 (results) | — |
| Jul 28, 2016 | 8-K Item 2.02 (results) | — |
| Jun 16, 2016 | 8-K Item 2.02 (results) | — |
| Feb 4, 2016 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on SNOA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.